← Leaderboards
Margaret O James
University Of Florida
$2,557,334
Attributed
$4,128,486
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $476.7K · FY2005–19$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$13,645,361 · 9
By mechanism
P42$10,043,451 · 2
R01$3,025,445 · 2
R21$402,875 · 1
R03$146,500 · 1
M01$27,090 · 3
Top collaborators
- Peter W. Stacpoole10 shared
- Charles E Wood2 shared
Most similar at University Of Florida
Same institution · by research overlap
- Peter W. Stacpoole$22,176,893
- Charles E Wood$10,365,562
Others in their field
Top investigators on “Enzymes”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Randall J Bateman · Washington University$83,824,814
- Stuart L Schreiber · Harvard University (Medical School)$49,424,554
- Jay D Keasling · University Of California-Berkeley$47,558,861
- David Heimbrook · Leidos Biomedical Research, Inc.$47,513,682
- Susan Abushakra · Alzheon, Inc.$47,265,244
Research focus
EnzymesLiverCytosolPharmaceutical PreparationsMetabolismEnvironmental ExposureEnvironmental ToxicologyIn VitroChlorohydrocarbonHazardous SubstancesIn VivoLinkResponseRecombinantsPhysiologicalProteinsRattusTissuesEnzyme ActivityAdverse EffectsExposure ToDehalogenationAdultAge Related
Grant awards (31)
Developmental Pharmacology of Mitochondrial and Cytosolic GSTZ1$340,075
R01 · FY2019 · GM · contact PI
Developmental Pharmacology of Mitochondrial and Cytosolic GSTZ1$340,075
R01 · FY2018 · GM · contact PI
Developmental Pharmacology of Mitochondrial and Cytosolic GSTZ1$388,915
R01 · FY2017 · GM · contact PI
Diversity Supplement to 2RO1 GM 099871$48,840
R01 · FY2017 · GM · contact PI
Developmental Pharmacology of Mitochondrial and Cytosolic GSTZ1$340,075
R01 · FY2016 · GM · contact PI
Developmental Pharmacology of cytosolic and mitochondrial GSTZ1-1/MAAI$321,530
R01 · FY2015 · GM · contact PI
Developmental Pharmacology of cytosolic and mitochondrial GSTZ1-1/MAAI$324,954
R01 · FY2014 · GM · contact PI
Developmental Pharmacology of cytosolic and mitochondrial GSTZ1-1/MAAI$312,950
R01 · FY2013 · GM · contact PI
Developmental Pharmacology of cytosolic and mitochondrial GSTZ1-1/MAAI$28,486
R01 · FY2013 · GM · contact PI
Developmental Pharmacology of cytosolic and mitochondrial GSTZ1-1/MAAI$293,530
R01 · FY2012 · GM · contact PI
Fetal Endocrine Disruption by Triclosan$183,125
R21 · FY2012 · ES
Fetal Endocrine Disruption by Triclosan$219,750
R21 · FY2011 · ES
Modulation of steroid sulfation by celecoxib-like drugs$73,250
R03 · FY2009 · CA · contact PI
MODULATION OF STEROID SULFONATION BY CELECOXIB-LIKE DRUGS$14,154
M01 · FY2009 · RR · contact PI
Modulation of steroid sulfation by celecoxib-like drugs$73,250
R03 · FY2008 · CA · contact PI
MODULATION OF STEROID SULFONATION BY CELECOXIB-LIKE DRUGS$6,504
M01 · FY2008 · RR · contact PI
MODULATION OF STEROID SULFONATION BY CELECOXIB-LIKE DRUGS$6,432
M01 · FY2007 · RR · contact PI
HEALTH EFFECTS OF CHLORINATED COMPOUNDS$128,670
P42 · FY2006 · ES · contact PI
HEALTH EFFECTS OF CHLORINATED COMPOUNDS$206,271
P42 · FY2005 · ES
HEALTH EFFECTS OF CHLORINATED COMPOUNDS$1,952,290
P42 · FY2004 · ES
HEALTH EFFECTS OF CHLORINATED COMPOUNDS$1,866,428
P42 · FY2003 · ES
HEALTH EFFECTS OF CHLORINATED COMPOUNDS$29,230
P42 · FY2003 · ES
HEALTH EFFECTS OF CHLORINATED COMPOUNDS$1,816,561
P42 · FY2002 · ES
BIOVAILABILITY OF CHLORINATED COMPOUNDS$131,644
P42 · FY2002 · ES
BIOVAILABILITY OF CHLORINATED COMPOUNDS$131,644
P42 · FY2002 · ES
HEALTH EFFECTS OF CHLORINATED COMPOUNDS$26,523
P42 · FY2002 · ES
HEALTH EFFECTS OF CHLORINATED COMPOUNDS$1,761,277
P42 · FY2001 · ES
BIOVAILABILITY OF CHLORINATED COMPOUNDS$131,644
P42 · FY2001 · ES
HEALTH EFFECTS OF CHLORINATED COMPOUNDS$1,729,625
P42 · FY2000 · ES
BIOAVAILABILITY AND METABOLISM OF DIETARY CARCINOGENS$286,015
R01 · FY2000 · ES
BIOVAILABILITY OF CHLORINATED COMPOUNDS$131,644
P42 · FY2000 · ES